Search

Search Constraints

You searched for: Author/Creator Kumar, Parag

Search Results

2. Risks of Ruxolitinib in STAT1 Gain-of-Function-Associated Severe Fungal Disease. (22nd September 2017)

3. Science and Evidence‐Based Review and Approval of COVID‐19 Vaccines: A Statement of Support for the US FDA. (27th January 2021)

4. 1413. A Phase IIa Efficacy, Safety, Tolerability and Pharmacokinetic (PK) Study of Encochleated Amphotericin B in Patients with Mucocutaneous (Esophogeal, Oropharyngeal, Vulvovaginal) Candidiasis Who are Refractory or Intolerant to Standard Non-Intravenous Therapies. (26th November 2018)

5. Pronerve Growth Factor Induces Angiogenesis via Activation of TrkA: Possible Role in Proliferative Diabetic Retinopathy. (12th August 2013)

6. Leveraging patient‐centric sampling for clinical drug development and decentralized clinical trials: Promise to reality. Issue 12 (8th October 2022)

8. Test Dose Pharmacokinetics in Pediatric Patients Receiving Once‐Daily IV Busulfan Conditioning for Hematopoietic Stem Cell Transplant: A Reliable Approach?. (14th December 2017)

10. Quantitative Benefit–Risk Assessment of P‐gp–Mediated Drug–Drug Interactions of Dabigatran Coadministered With Pharmacokinetic Enhancers in Patients With Renal Impairment. Issue 1 (10th December 2020)